Moreover, the inhibition of IDO-1 activity by 1-MT, coupled with in situ-generated nitric oxide, normalizes tumor vasculature, reprogramming the immunosuppressive TME into an immunostimulatory phenotype. Here, IDO1 is linked to neoplasm.